Grants and Contributions:
Grant or Award spanning more than one fiscal year. (2017-2018 to 2018-2019)
Currently, Vivosonic (the Partner) manufactures the IntegrityTM V500, a system unique to the market for itsx000D
ability to acquire auditory brainstem responses in less-than-ideal clinical environments. This system is currentlyx000D
used to identify non-organic hearing loss using an objective method that allows accurate measurements even inx000D
difficult-to-test patients.x000D
The proposed project aims to further extend the capability of this product by creating a novel protocol tox000D
objectively identify tinnitus, using a gap-in-noise paradigm. Currently the gap-in-noise method for tinnitusx000D
detection has been validated on mice (Lowe et al. 2015); its application to humans has been precluded due tox000D
lack of existing technology. Current methods to diagnose tinnitus are subjective and behavioral-based; thisx000D
limits quantitative evaluation and prevents assessment in difficult-to-test populations, such as paediatricx000D
patients and patients with developmental disabilities.